| Literature DB >> 26463629 |
Shun-chang Wang1, Da-sen Chai2, Chuan-bo Chen2, Zheng-ye Wang2, Lei Wang2.
Abstract
Hematopoietic pre-B cell leukemia transcription factor (PBX)-interacting protein (HPIP), a co-repressor for the transcription factor PBX, is a nucleo-cytoplasmic shuttling protein. Increasing evidence suggests that HPIP is an oncogene which is frequently overexpressed in many human carcinomas. However, the role of HPIP in thyroid carcinoma is still unclear. Therefore, in this study, we investigated the role of HPIP in thyroid carcinoma, and explored the underling mechanism. We found that the expression of HPIP is upregulated in thyroid carcinoma cell lines. Knockdown of HPIP inhibits thyroid carcinoma cell proliferation, migration/invasion and epithelial-mesenchymal transition (EMT). HPIP knockdown also reduces thyroid tumor growth in nude mice. Furthermore, knockdown of HPIP significantly inhibits the expression of phosphorylated PI3K and AKT in thyroid carcinoma cells. Taken together, these results suggest that knockdown of HPIP inhibits the proliferation, migration and EMT by suppressing the PI3K/AKT pathway, and HPIP may be a potential therapeutic target for the treatment of thyroid carcinoma.Entities:
Keywords: Epithelial–mesenchymal transition (EMT); Hematopoietic pre-B cell leukemia transcription factor (PBX)-interacting protein (HPIP); Migration; Proliferation; Thyroid carcinoma
Mesh：
Substances：
Year: 2015 PMID： 26463629 DOI： 10.1016/j.biopha.2015.08.027
Source DB: PubMed Journal: Biomed Pharmacother ISSN： 0753-3322 Impact factor: 6.529